Skip Navigation

This Article
Right arrow Print PDF (1354K)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Hurwitz, D. R.
Right arrow Articles by Sarver, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hurwitz, D. R.
Right arrow Articles by Sarver, N.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nucleic Acids Research, 1987, Vol. 15, No. 17 7137-7153
© 1987


Articles

Optimizing gene expression in BPV-transformed cells: effects of cell type on enhancer/promoter interaction

David R. Hurwitz, Roland Hodges, William Drohan and Nava Sarver

Rorer Biotechnology Inc., Molecular Biology Development Division Springfield, VA 22151, USA

Received March 21, 1987. Revised July 29, 1987. Accepted July 29, 1987.

We have compared several combinations of enhancers and promoters in expressing the chloramphenical acetyl transferase gene in transient assays, in mouse C127, the most widely used host cell for the bovine papilloma virus (BPV) expression vector. Of the various combinations tested, the unit comprised of the SV40 enhancer and adenovirus type 2 major late promoter (NLP) was the most active in BPV transformed C127 cells. We further demonstrate that untransformed and BPV transformed C127 cells respond differently to the various enhancer/promoter combinations tested.

Moving the SV40 enhancer closer to the cap site of a complete MLP (from –414 to –107) reduced potentiation to less than half in BPV transformed cells. The level of potentiation with enhancer at either site was similar in human HeLa cells.

In BPV transformed C127 cells, the SV40 enhancer and the MLP (at the –414 site) supports 4–5 fold greater levels of expression than the murine sarcoma virus (MSV) enhancer/mouse metallothionein (NT) promoter which has previously been extremely effective in BPV vectors. Our findings provide a basis for the improvement of the BPV vector system in supporting increased levels of expression of proteins of important therapeutic application.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.